Fundraising FoxLucid Genomics
Berlin, DE · 1 known investors
Find your way into Lucid Genomics
Sign up to see every warm intro you have to Lucid Genomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lucid Genomics team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lucid Genomics provides a software platform for genomic analysis tailored to clinicians, specializing in long-read sequencing interpretation for rare disease, hereditary cancer, and pharmacogenomics diagnostics. The platform integrates variant calling, prioritization, interpretation, and reporting with HPO-based phenotype matching and advanced visualization tools for structural variants.
Founders & leadership
SM
Stefan MundlosFounder
MV
Martin VingronFounder
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountPre-seedSep 2024 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Lucid Genomics do?
- Lucid Genomics provides a software platform for genomic analysis tailored to clinicians, specializing in long-read sequencing interpretation for rare disease, hereditary cancer, and pharmacogenomics diagnostics. The platform integrates variant calling, prioritization, interpretation, and reporting with HPO-based phenotype matching and advanced visualization tools for structural variants.
- Who founded Lucid Genomics?
- Lucid Genomics was founded by Stefan Mundlos, Martin Vingron.
- Who are Lucid Genomics's investors?
- Lucid Genomics's investors include Caesar Ventures.
- Where is Lucid Genomics headquartered?
- Lucid Genomics is headquartered in Berlin, DE.